Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 25, 2012

Abbott Nabs Distribution Rights to Biofortuna’s Freeze-Dried HLA Typing Kits

  • Abbott extended its exclusive distribution deal for U.K. firm Biofortuna’s SSPGo® range of freeze-dried HLA typing kits to include France, Spain, Portugal, and the Benelux countries. Abbott now effectively has exclusive global distribution rights to the SSPGo products, Verdict interpretation software, and future kit updates.

    Biofortuna’s HLA molecular diagnostic kit products are based on a freeze-dried technology that stabilizes the PCR reaction mix, including polymerase. The kits are stable at ambient temperature, and require only the addition of DNA to the predispensed PCR reaction mix. The freeze-dried manufacturing technology is separately being offered as a contract service for diagnostic companies.

    Last month Biofortuna raised £2.1 million in an investment round with new and existing investors to support expansion of its manufacturing operations and fund the development of new products in areas including companion diagnostics, antibody screening, and disease identification.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »